ABBV Jan 2023 180.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 03:15PM EDT
| Previous close | 3.5100 |
| Open | 2.7700 |
| Bid | 3.0500 |
| Ask | 3.3000 |
| Strike | 180.00 |
| Expiry date | 2023-01-20 |
| Day's range | 2.7500 - 2.8400 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.18k |
- Zacks
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
- Zacks
Pharma Stock Roundup: FDA Nod to PFE COVID Jab for Age 5-11 & LLY's Tirzepatide
FDA grants emergency approval to Pfizer's COVID-19 vaccine for use in children 5- to 11-year old and approves Lilly's (LLY) novel diabetes treatment, Mounjaro (tirzepatide).
- PR Newswire
AbbVie Submits New Drug Application to U.S. FDA for Investigational ABBV-951 (Foscarbidopa/Foslevodopa) for the Treatment of Advanced Parkinson's Disease
AbbVie (NYSE: ABBV) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ABBV-951 (foscarbidopa/foslevodopa) for the treatment of motor fluctuations in patients with advanced Parkinson's disease (PD).
© 2022 Yahoo. All rights reserved.
